Literature DB >> 2370896

Choice of antimicrobial agents for M. avium disease based on quantitative tests of drug susceptibility.

L B Heifets, M D Iseman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370896     DOI: 10.1056/NEJM199008093230615

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Antimycobacterial susceptibility testing: present practices and future trends.

Authors:  C B Inderlied
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 2.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 3.  Mycobacterium avium complex: advances in therapy.

Authors:  D V Havlir
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 4.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

5.  Enhancement of antibiotic susceptibility and suppression of Mycobacterium avium complex growth by poloxamer 331.

Authors:  R L Hunter; C Jagannath; A Tinkley; C A Behling; F Nolte
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

6.  Use of mefloquine in multidrug-resistant Mycobacterium avium complex pulmonary disease in an HIV-negative patient.

Authors:  Juan Ramirez; Carol Mason; Juzar Ali
Journal:  Curr Ther Res Clin Exp       Date:  2007-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.